Viewing Study NCT00064350


Ignite Creation Date: 2025-12-24 @ 4:57 PM
Ignite Modification Date: 2026-01-10 @ 4:23 PM
Study NCT ID: NCT00064350
Status: COMPLETED
Last Update Posted: 2023-06-29
First Post: 2003-07-08
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
Sponsor: Eastern Cooperative Oncology Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent non-small cell lung cancer View
None stage IIIB non-small cell lung cancer View
None stage IV non-small cell lung cancer View
None sorafenib View